Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer.
Chen Y, Sun J, Luo Y, Liu J, Wang X, Feng R, Huang J, Du H, Li Q, Tan J, Ren G, Wang X, Li H.
Chen Y, et al. Among authors: li h, li q.
J Transl Med. 2022 Dec 23;20(1):615. doi: 10.1186/s12967-022-03807-8.
J Transl Med. 2022.
PMID: 36564797
Free PMC article.